Bank of America’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-26,434
| Closed | -$79K | – | 6673 |
|
|
2016
Q3 | $79K | Sell |
26,434
-15,088
| -36% | -$45.1K | ﹤0.01% | 4793 |
|
|
2016
Q2 | $61K | Sell |
41,522
-4,807
| -10% | -$7.06K | ﹤0.01% | 4960 |
|
|
2016
Q1 | $171K | Sell |
46,329
-17,096
| -27% | -$63.1K | ﹤0.01% | 4446 |
|
|
2015
Q4 | $641K | Sell |
63,425
-14,267
| -18% | -$144K | ﹤0.01% | 3804 |
|
|
2015
Q3 | $1.06M | Sell |
77,692
-40,423
| -34% | -$549K | ﹤0.01% | 3487 |
|
|
2015
Q2 | $2.24M | Sell |
118,115
-81,076
| -41% | -$1.54M | ﹤0.01% | 2661 |
|
|
2015
Q1 | $5.21M | Sell |
199,191
-344
| -0.2% | -$9K | ﹤0.01% | 1957 |
|
|
2014
Q4 | $4.18M | Sell |
199,535
-1,095,307
| -85% | -$22.9M | ﹤0.01% | 2080 |
|
|
2014
Q3 | $43.2M | Buy |
1,294,842
+587,694
| +83% | +$19.6M | 0.01% | 722 |
|
|
2014
Q2 | $22.7M | Buy |
707,148
+260,171
| +58% | +$8.35M | 0.01% | 1045 |
|
|
2014
Q1 | $20.6M | Buy |
446,977
+150,938
| +51% | +$6.97M | 0.01% | 1034 |
|
|
2013
Q4 | $21M | Buy |
296,039
+58,272
| +25% | +$4.13M | 0.01% | 993 |
|
|
2013
Q3 | $20.4M | Buy |
237,767
+170,626
| +254% | +$14.6M | 0.01% | 988 |
|
|
2013
Q2 | $4.25M | Buy |
+67,141
| New | +$4.25M | ﹤0.01% | 1864 |
|